The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence
Crossref DOI link: https://doi.org/10.1007/s40273-016-0417-9
Published Online: 2016-06-11
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lomas, James
Llewellyn, Alexis
Soares, Marta
Simmonds, Mark
Wright, Kath
Eastwood, Alison
Palmer, Stephen
Funding for this research was provided by:
National Institute for Health Research (Health Technology Appraisal Programme 12/66/01)
License valid from 2016-06-11